Rohto Pharmaceutical Co (4527N) Q3 2025 Earnings Report
MX:4527N Q3 2025 EPS Results
- Actual EPS
- MXN 5.60
- Consensus EPS
- MXN 5.25
- Beat/Miss
- Beat by +MXN 0.35
- One Year Ago EPS
- MXN 6.20
MX:4527N Q3 2025 Revenue Results
- Actual Revenue
- MXN 10.57B
- Expected Revenue
- MXN 10.89B
- Beat/Miss
- Missed by -MXN 320.89M
- YoY Revenue Growth
- +2.30%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 02/12/2026
- Time
- TBA
- Conference Call
- Thursday, February 12, 2026
MX:4527N Upcoming Earnings
Rohto Pharmaceutical Co's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q3 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2025 Earnings Slide Deck
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4527N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q2) | 3.89- | 3.1 | ― | ― |
| Aug 06, 2026 | 2026 (Q1) | 4.745.61 | 6.2 | -9.50% (-0.59) | |
| May 13, 2026 | 2025 (Q4) | 3.613.14 | 3.26 | -3.54% (-0.12) | |
| Feb 12, 2026 | 2025 (Q3) | 5.255.60 | 6.2 | -9.71% (-0.60) | |
| Nov 13, 2025 | 2025 (Q2) | 2.973.10 | 2.32 | 33.76% (+0.78) | |
| Aug 06, 2025 | 2025 (Q1) | ―6.20 | 4.42 | 40.10% (+1.77) | |
| May 13, 2025 | 2024 (Q4) | 2.973.26 | 2.49 | 30.69% (+0.77) | |
| Feb 12, 2025 | 2024 (Q3) | 5.846.20 | 4.99 | 24.26% (+1.21) | |
| Nov 13, 2024 | 2024 (Q2) | 4.172.32 | 3.91 | -40.83% (-1.60) | |
| Aug 07, 2024 | 2024 (Q1) | 4.754.42 | 4.74 | -6.70% (-0.32) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
